iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Hoey Investments Inc.

Hoey Investments Inc. cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 55.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 235 shares of the financial services provider’s stock after selling 295 shares during the quarter. Hoey Investments Inc.’s holdings in iShares Biotechnology ETF were worth $30,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in IBB. Brighton Jones LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth about $201,000. Kestra Private Wealth Services LLC lifted its holdings in iShares Biotechnology ETF by 25.3% in the fourth quarter. Kestra Private Wealth Services LLC now owns 6,365 shares of the financial services provider’s stock worth $842,000 after purchasing an additional 1,284 shares during the period. Bogart Wealth LLC lifted its holdings in iShares Biotechnology ETF by 66.3% in the fourth quarter. Bogart Wealth LLC now owns 434 shares of the financial services provider’s stock worth $57,000 after purchasing an additional 173 shares during the period. Vontobel Holding Ltd. lifted its holdings in iShares Biotechnology ETF by 20.2% in the fourth quarter. Vontobel Holding Ltd. now owns 2,959 shares of the financial services provider’s stock worth $391,000 after purchasing an additional 497 shares during the period. Finally, Banque Pictet & Cie SA lifted its holdings in iShares Biotechnology ETF by 26.1% in the fourth quarter. Banque Pictet & Cie SA now owns 8,690 shares of the financial services provider’s stock worth $1,149,000 after purchasing an additional 1,800 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.8%

IBB stock opened at $128.00 on Friday. The company has a market capitalization of $5.60 billion, a P/E ratio of 23.96 and a beta of 0.84. The company has a 50-day simple moving average of $121.95 and a 200 day simple moving average of $130.48. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were issued a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.